ylliX - Online Advertising Network
Company Ticker News

AbbVie Acquires Syndesi Therapeutics, Strengthening Neuroscience Portfolio

AbbVie Acquires Syndesi Therapeutics, Strengthening Neuroscience Portfolio

<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>

NORTH CHICAGO, Ill., March 1, 2022 /PRNewswire/ — AbbVie (NYSE: ABBV) today announced it has completed the acquisition of Syndesi Therapeutics SA, which will help to expand AbbVie’s neuroscience portfolio.

...read full article on PRNewsWire

ylliX - Online Advertising Network